loadpatents
Patent applications and USPTO patent grants for Roth; Howard S..The latest application filed is for "macrocyclic immunomodulators".
Patent | Date |
---|---|
Salt forms of a complement component C5A receptor Grant 11,427,541 - Singh , et al. August 30, 2 | 2022-08-30 |
Macrocyclic Immunomodulators App 20220119405 - MALATHONG; Viengkham ;   et al. | 2022-04-21 |
Macrocyclic immunomodulators Grant 11,059,834 - Malathong , et al. July 13, 2 | 2021-07-13 |
Immunomodulator Compounds App 20210147356 - LANGE; Christopher ;   et al. | 2021-05-20 |
Salt Forms Of A Complement Component C5a Receptor App 20210139427 - SINGH; Rajinder ;   et al. | 2021-05-13 |
Procaspase 3 Activation By Combination Therapy App 20210128551 - HERGENROTHER; Paul J. ;   et al. | 2021-05-06 |
Immunomodulator compounds Grant 10,919,852 - Lange , et al. February 16, 2 | 2021-02-16 |
Indanes As Pd-l1 Inhibitors App 20210008049 - MALATHONG; Viengkham ;   et al. | 2021-01-14 |
Procaspase 3 activation by combination therapy Grant 10,888,560 - Hergenrother , et al. January 12, 2 | 2021-01-12 |
Compounds For Treatment Of Pd-l1 Diseases App 20210002229 - MALATHONG; Viengkham ;   et al. | 2021-01-07 |
Macrocyclic Immunomodulators App 20200055869 - MALATHONG; Viengkham ;   et al. | 2020-02-20 |
Macrocyclic immunomodulators Grant 10,392,405 - Malathong , et al. A | 2019-08-27 |
Immunomodulator Compounds App 20190135745 - LANGE; Christopher ;   et al. | 2019-05-09 |
Procaspase 3 Activation By Combination Therapy App 20190099418 - HERGENROTHER; Paul J. ;   et al. | 2019-04-04 |
Macrocyclic Immunomodulators App 20190048022 - MALATHONG; Viengkham ;   et al. | 2019-02-14 |
Procaspase 3 activation by combination therapy Grant 10,085,977 - Hergenrother , et al. October 2, 2 | 2018-10-02 |
Substituted piperazinyl acetohydrazide procaspase-activating compounds Grant 9,663,482 - Hergenrother , et al. May 30, 2 | 2017-05-30 |
Procaspase 3 Activation By Combination Therapy App 20160346277 - HERGENROTHER; Paul J. ;   et al. | 2016-12-01 |
Procaspase 3 activation by combination therapy Grant 9,399,035 - Hergenrother , et al. July 26, 2 | 2016-07-26 |
Enzyme-activating Compounds And Compositions App 20160176833 - Hergenrother; Paul J. ;   et al. | 2016-06-23 |
Enzyme-activating compounds and compositions Grant 9,249,116 - Hergenrother , et al. February 2, 2 | 2016-02-02 |
Procaspase 3 Activation By Combination Therapy App 20150017264 - Hergenrother; Paul J. ;   et al. | 2015-01-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.